Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Compression Force Impact Analysis on Tablet Hardness – V 2.0

Posted on By

Tablets: SOP for Compression Force Impact Analysis on Tablet Hardness – V 2.0

Standard Operating Procedure for Compression Force Impact Analysis on Tablet Hardness

Department Tablet
SOP No. SOP/TAB/099/2025
Supersedes SOP/TAB/099/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for analyzing the impact of compression force on tablet hardness, ensuring that tablets meet the required hardness specifications for product quality and performance.

2. Scope

This SOP applies to the compression force impact analysis on tablets during manufacturing, ensuring that the compression process does not adversely affect the tablet hardness, which is critical for handling, storage, and dissolution.

3. Responsibilities

  • Manufacturing Personnel: Responsible for adjusting compression force during the tablet compression process and ensuring that the tablet hardness meets the specified criteria.
  • Quality Control (QC): Responsible for conducting the compression force impact analysis, testing tablet hardness, and ensuring that the tablets comply with hardness specifications.
  • Quality Assurance (QA): Ensures that the compression force impact analysis procedure is followed, reviews the test results, and approves the batch for release based on the tablet hardness data.

4. Accountability

The QC Manager is accountable for ensuring the proper execution of compression force impact

analysis. The QA Manager is responsible for reviewing and approving the batch release based on hardness test results.

See also  Tablets: SOP for pH Adjustment Analysis in Enteric-Coating Materials - V 2.0

5. Procedure

5.1 Sample Collection

  1. Collect a representative sample of tablets from the batch, as specified in the batch record or pharmacopeial guidelines (usually a minimum of 10 tablets or as specified).
  2. Ensure that the tablets are free from defects such as cracks, chips, or discoloration that could affect the analysis.
  3. Label the sample appropriately for identification during testing.

5.2 Preparation of Compression Force Testing Apparatus

  1. Ensure that all testing equipment, such as hardness testers, compression machines, and load cells, are calibrated and functioning properly.
  2. Set up the compression machine to the specified compression force ranges, based on the tablet formulation and the batch record specifications.
  3. Verify that the testing environment (e.g., temperature and humidity) meets the specifications for the compression force impact test.

5.3 Performing Compression Force Impact Test

  1. Set the compression machine to a predetermined compression force based on the tablet formulation and product specifications.
  2. Compress a set of tablets at varying compression forces to evaluate the relationship between the compression force and tablet hardness.
  3. Measure the tablet hardness using an appropriate hardness tester (e.g., Pfizer hardness tester, or a similar device) at each compression force setting.
  4. Record the tablet hardness values for each compression force level (Annexure-1).
See also  Tablets: SOP for Robustness Testing of Analytical Methods for Tablets - V 2.0

5.4 Data Recording and Calculation

  1. Record the compression force and corresponding tablet hardness values in the batch record (Annexure-1).
  2. Analyze the data to determine the correlation between compression force and tablet hardness. The goal is to identify the optimal compression force that results in the desired tablet hardness without causing any defects.
  3. Calculate the average tablet hardness for each compression force setting and identify the optimum force range that meets the product specifications for hardness.

5.5 Acceptance Criteria

  1. The tablet hardness must fall within the specified range outlined in the batch record or product specifications, which is typically in the range of 4–8 kg (or as specified).
  2. If the tablet hardness falls outside the specified range, investigate and document the findings in the deviation report (Annexure-2).
  3. Adjust the compression force settings and perform re-testing if necessary to meet the acceptance criteria.

5.6 Documentation and Record-Keeping

  1. Document all test results, including compression force, tablet hardness, and any deviations, in the batch record (Annexure-1).
  2. Ensure that all records are signed, dated, and stored according to the company’s record retention policy for future audits and inspections.
  3. Maintain raw data, test results, and supporting documentation for future reference and regulatory compliance.

5.7 Post-Test Cleanup

  1. Clean all equipment used for compression force testing, including the hardness tester, compression machine, and sample containers, according to the cleaning SOP to prevent cross-contamination between tests.
  2. Ensure that all testing equipment is properly maintained and calibrated for future use.
See also  Tablets: SOP for Physical Testing of Immediate Release Tablets - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • API: Active Pharmaceutical Ingredient
  • Kg: Kilogram

7. Documents

  1. Batch Record (Annexure-1)
  2. Deviation Report (Annexure-2)

8. References

  • USP <1216> – Tablet Hardness Testing
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • European Pharmacopoeia (EP) – Tablet Hardness Standards

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Batch Record

Batch Number Tablet Sample Compression Force (kg) Hardness (kg) Result
Batch 001 Tablet Sample 5 6.2 Pass

Annexure-2: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/12/2025 Batch 001 Tablet hardness outside specification Adjusted compression force and re-tested John Doe

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated Compression Force Ranges Refined tablet compression process QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Job Safety Analysis for Tablet Metal Detector
Next Post: Ointments: SOP for Handling Rejected Packed Units – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version